DISC MEDICINE INC's ticker is and the CUSIP is 254604101. A total of 122 filers reported holding DISC MEDICINE INC in Q2 2024. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $24,943,406 | -67.7% | 553,437 | -55.4% | 0.60% | -55.5% |
Q1 2024 | $77,194,057 | +30.6% | 1,239,866 | +21.2% | 1.35% | +2.4% |
Q4 2023 | $59,091,079 | +40.4% | 1,023,045 | +14.2% | 1.32% | -6.1% |
Q3 2023 | $42,077,214 | +27.6% | 895,641 | +20.6% | 1.40% | +47.0% |
Q2 2023 | $32,982,007 | – | 742,838 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 2,745,335 | $128,975,838 | 19.98% |
Foresite Capital Management V, LLC | 243,513 | $11,440,241 | 18.25% |
Bain Capital Life Sciences Investors, LLC | 1,332,545 | $62,602,964 | 7.00% |
Trustees of Columbia University in the City of New York | 78,682 | $3,696,480 | 6.80% |
5AM Venture Management, LLC | 438,442 | $20,598,005 | 5.93% |
ACUTA CAPITAL PARTNERS, LLC | 138,198 | $6,492,542 | 4.35% |
Paradigm Biocapital Advisors LP | 1,272,279 | $59,771,667 | 4.06% |
Novo Holdings A/S | 1,090,772 | $51,244,485 | 3.79% |
Orbimed Advisors | 2,269,637 | $106,627,546 | 2.26% |
Frazier Life Sciences Management, L.P. | 655,000 | $30,771,900 | 2.04% |